SCHEMBL129293

SCHEMBL129293

CCCCCC(=O)OCC(C)C

nearest known ligand 0.72

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.72
LMNA P02545 4/20 0.65
ALDH1A1 P00352 1/20 0.65
KDM4E B2RXH2 1/20 0.62
DUSP3 P51452 1/20 0.62
MEN1 O00255 1/20 0.62
KMT2A Q03164 1/20 0.62
DGKA P23743 2/20 0.61
CYP3A4 P08684 1/20 0.59
TSHR P16473 1/20 0.59
ATM Q13315 1/20 0.59
TDP1 Q9NUW8 1/20 0.59
PRKCA P17252 3/20 0.59
PRKCE Q02156 1/20 0.59
PRKCQ Q04759 1/20 0.59
PRKCD Q05655 1/20 0.59
PAM P19021 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1869509 1.00 MAPT (0.72) MAPTLMNAALDH1A1KDM4EDUSP3
SCHEMBL332921 0.98 MAPT (0.76) MAPTLMNAALDH1A1KDM4EDUSP3
SCHEMBL2835498 0.98 MAPT (0.76) MAPTLMNAALDH1A1KDM4EDUSP3
SCHEMBL333509 0.98 MAPT (0.76) MAPTLMNAALDH1A1KDM4EDUSP3
SCHEMBL333109 0.98 MAPT (0.76) MAPTLMNAALDH1A1KDM4EDUSP3
SCHEMBL33706 0.98 MAPT (0.76) MAPTLMNAALDH1A1KDM4EDUSP3
SCHEMBL2831338 0.98 MAPT (0.76) MAPTLMNAALDH1A1KDM4EDUSP3
SCHEMBL2397946 0.98 MAPT (0.76) MAPTLMNAALDH1A1KDM4EDUSP3
SCHEMBL2396865 0.98 MAPT (0.76) MAPTLMNAALDH1A1KDM4EDUSP3
SCHEMBL128511 0.98 MAPT (0.76) MAPTLMNAALDH1A1KDM4EDUSP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 902 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12404479-B2 Laundry detergent composition containing graft copolymer and benefit agent THE PROCTER & GAMBLE COMPANY (US) 2025-09-02 US claimed
EP-4555060-A1 LAUNDRY DETERGENT COMPOSITION CONTAINING GRAFT COPOLYMER AND BENEFIT AGENT The Procter & Gamble Company (US) 2025-05-21 EP claimed
CN-118619317-B Alumina powder and preparation method and application thereof 潮州三环(集团)股份有限公司 2025-02-25 CN claimed
CN-110981873-B Preparation method for synthesizing pyrroloquinoline quinone by five-step method 江西农业大学 2025-01-24 CN claimed
CN-118984866-A Agave spirit replica 艾娃食品实验室股份有限公司 2024-11-19 CN claimed
US-20240306688-A1 METHOD OF MITIGATING OFF-ODORS GIVAUDAN SA (CH) 2024-09-19 US claimed
EP-4430154-A1 AGAVE SPIRIT REPLICAS AVA FOOD LABS, INC. (US) 2024-09-18 EP claimed
CN-118619317-A Alumina powder and preparation method and application thereof 潮州三环(集团)股份有限公司 2024-09-10 CN claimed
CN-118501118-A Biological fluorescence energy resonance transfer detection system based on cells and application 汉王科技股份有限公司 2024-08-16 CN claimed
EP-4391827-A1 METHOD OF MITIGATING OFF-ODORS Givaudan SA (CH) 2024-07-03 EP claimed
EP-1716159-A2 CYCLIC SILOXANE COMPOSITIONS FOR THE RELEASE OF ACTIVE INGREDIENTS General Electronic Company (US) 2006-11-02 EP claimed
EP-1697386-A1 ACTIVE INGREDIENT-RELEASING CYCLIC SILOXANES General Electric Company A Corporation of the State of New York (US) 2006-09-06 EP claimed
US-20060138399-A1 Removing solution DAIKIN INDUSTRIES, LTD. (JP) 2006-06-29 US claimed
CN-1678961-A Removing solution DAIKIN IND LTD (JP) 2005-10-05 CN claimed
WO-2005066187-A1 ACTIVE INGREDIENT-RELEASING CYCLIC SILOXANES GENERAL ELECTRIC COMPANY (US) 2005-07-21 WO claimed
WO-2005066186-A2 CYCLIC SILOXANE COMPOSITIONS FOR THE RELEASE OF ACTIVE INGREDIENTS GENERAL ELECTRIC COMPANY (US) 2005-07-21 WO claimed
US-20050136022-A1 Cyclic siloxane compositions for the release of active ingredients MOMENTIVE PERFORMANCE MATERIALS INC. 2005-06-23 US claimed
US-20050136021-A1 Active-releasing cyclic siloxanes MOMENTIVE PERFORMANCE MATERIALS INC. 2005-06-23 US claimed
EP-1536291-A1 REMOVING SOLUTION Daikin Industries, Ltd. (JP) 2005-06-01 EP claimed
US-4657883-A UNSUPPORTED TITANIUM HALIDE COORDINATION CATALYST; POLYMER PRETREATMENT AMOCO CORPORATION (US) 1987-04-14 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050136022-A1 Cyclic siloxane compositions for the release of active ingredients F9, RPL39, ECPAS MAPT 815/4885LMNA 568/4885ALDH1A1 44/4885
US-20050136021-A1 Active-releasing cyclic siloxanes F9, RPL39, ALDH16A1 MAPT 1453/4885LMNA 882/4885ALDH1A1 57/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.